- Home
- CATX vs JRS Comparison
CATX vs JRS Comparison
Compare CATX & JRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATX
- JRS
- Stock Information
- Founded
- CATX 1983
- JRS 2001
- Country
- CATX United States
- JRS United States
- Employees
- CATX N/A
- JRS N/A
- Industry
- CATX Medical/Dental Instruments
- JRS Finance/Investors Services
- Sector
- CATX Health Care
- JRS Finance
- Exchange
- CATX Nasdaq
- JRS Nasdaq
- Market Cap
- CATX 239.0M
- JRS 224.5M
- IPO Year
- CATX N/A
- JRS N/A
- Fundamental
- Price
- CATX $3.67
- JRS $7.58
- Analyst Decision
- CATX Strong Buy
- JRS
- Analyst Count
- CATX 11
- JRS 0
- Target Price
- CATX $12.90
- JRS N/A
- AVG Volume (30 Days)
- CATX 954.5K
- JRS 86.6K
- Earning Date
- CATX 08-13-2025
- JRS 01-01-0001
- Dividend Yield
- CATX N/A
- JRS 8.87%
- EPS Growth
- CATX N/A
- JRS N/A
- EPS
- CATX N/A
- JRS N/A
- Revenue
- CATX $1,471,000.00
- JRS N/A
- Revenue This Year
- CATX N/A
- JRS N/A
- Revenue Next Year
- CATX $11.99
- JRS N/A
- P/E Ratio
- CATX N/A
- JRS N/A
- Revenue Growth
- CATX N/A
- JRS N/A
- 52 Week Low
- CATX $1.60
- JRS $5.95
- 52 Week High
- CATX $16.55
- JRS $8.00
- Technical
- Relative Strength Index (RSI)
- CATX 44.88
- JRS 34.42
- Support Level
- CATX $3.88
- JRS $7.80
- Resistance Level
- CATX $4.28
- JRS $7.88
- Average True Range (ATR)
- CATX 0.27
- JRS 0.12
- MACD
- CATX -0.08
- JRS -0.03
- Stochastic Oscillator
- CATX 2.32
- JRS 9.30
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
About JRS Nuveen Real Estate Income Fund of Beneficial Interest
Nuveen Real Estate Income Fund is a diversified closed-end investment company. The Fund invests primarily in income-producing common stocks, preferred stocks, convertible preferred stocks, and debt securities issued by real estate companies.